Bionano Genomics, Inc. Financial Ratios — BNGO Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-187.43	-105.85	-108.4	-90.68	-33.11	-38.74	-89.09	-76.97	-35.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	47.32	36.55	27.41	33.18	32.61	21.54	21.38	26.49	1.23	46.25
EBITDA Margin (%)	-295.22	-222.1	-159.11	-244.31	-435.99	-410.05	-438.31	-341.43	-201.62	-82.81
Operating Margin (%)	-311.63	-237.92	-170.12	-255.44	-453.38	-428.79	-473.7	-379.95	-247.85	-116.95
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-277.29	-245.63	-154	-294.13	-483.09	-434.64	-470.15	-643.57	-363.87	-92.35
Profit Margin (%)	-277.48	-245.82	-154.13	-294.34	-483.43	-402.84	-476.93	-643.74	-363.98	-92.59
Net Income to Common Margin (%)	-277.48	-245.82	-154.13	-294.34	-483.43	-402.84	-476.93	-643.74	-363.98	-92.59
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	7	7	9	20	16	11	12	10	7	7
ST Debt	1	7	- -	20	- -	2	3	2	3	1
LT Debt	6	- -	9	- -	16	9	9	7	4	6
Total Debt/EBITDA	-0.33	-0.32	-0.47	-0.81	-0.44	-0.15	-0.1	-0.08	-0.11	-0.29
Net Debt/EBITDA	-0.07	-0.27	0.39	-0.11	0.6	0.33	0.04	-0.42	0.15	0.13
Total Debt/EBIT	-0.31	-0.3	-0.44	-0.78	-0.42	-0.14	-0.09	-0.07	-0.09	-0.21
Net Debt/EBIT	-0.07	-0.25	0.37	-0.11	0.57	0.32	0.04	-0.38	0.12	0.09
EBITDA to Interest Expense	-42.66	-35.72	-13.83	-10.82	-14.72	-79.54	-408.92	41.12	-26.15	-79.22
EBITDA-CapEx/Interest Expense	-45.53	-37.45	-14.07	-10.85	-14.72	-81.11	-420	41.68	-26.19	-79.22
EBIT to Interest Expense	-45.03	-38.27	-14.78	-11.32	-15.3	-83.17	-441.94	45.76	-32.14	-111.88
Interest Expense	- -	1	1	2	3	1	- -	-3	2	- -
Common Equity/Total Assets	-208.96	-534.9	-293.36	-339.56	-237.66	-57.3	-113.4	-271.08	-904.17	-977.96
Long-Term Debt/Equity (%)	- -	- -	89.07	- -	46.53	2.65	3.66	7.46	10.41	13.44
Long-Term Debt/Capital (%)	-24.91	- -	-14.17	- -	-12.82	-4.35	-2.71	-1.26	-0.54	-0.84
Long-Term Debt/Total Assets (%)	40.89	- -	36.41	- -	27.01	2.37	2.97	3.35	4.81	8.11
Total Debt/Equity (%)	-24.33	-13.4	89.07	555.8	46.53	3.17	4.68	9.99	19.6	15.57
Total Debt/Capital (%)	-27.33	-14.16	-14.17	-24.35	-12.82	-5.21	-3.46	-1.68	-1.01	-0.97
Total Debt/Total Assets (%)	44.86	66.33	36.41	66.49	27.01	2.84	3.79	4.48	9.05	9.4
Net Debt to Equity	-5.08	-11.36	-73.92	76.75	-63.06	-7.29	-2.04	53.93	-25.93	-6.73
Net Debt/Capital (%)	-4.69	-11.75	9.34	-2.78	13.34	10.68	1.49	-8.8	1.32	0.42
EBITDA	-20	-21	-19	-25	-37	-74	-122	-123	-62	-24
EBITDA-CapEx	-21	-22	-19	-25	-37	-75	-125	-125	-62	-24
Operating Income (Loss)	-21	-23	-20	-26	-39	-77	-132	-137	-76	-33

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.56	0.06	3.65	0.66	4.3	11.47	3.15	0.67	0.25	0.84
Current Ratio	1.15	0.43	5.09	1.07	5.23	12.47	4.38	1.4	1.06	1.98
Quick Ratio	0.76	0.26	4.65	0.9	4.61	11.72	3.36	0.76	0.38	1.07
CFO/Avg Current Liab	- -	-1.6	-1.88	-1.91	-2.17	-4.67	-4.32	-1.84	-1	-0.54
Common Equity/Total Assets	-208.96	-534.9	-293.36	-339.56	-237.66	-57.3	-113.4	-271.08	-904.17	-977.96
Long-Term Debt/Equity (%)	- -	- -	89.07	- -	46.53	2.65	3.66	7.46	10.41	13.44
Long-Term Debt/Capital (%)	-24.91	- -	-14.17	- -	-12.82	-4.35	-2.71	-1.26	-0.54	-0.84
Long-Term Debt/Total Assets (%)	40.89	- -	36.41	- -	27.01	2.37	2.97	3.35	4.81	8.11
Total Debt/Equity (%)	-24.33	-13.4	89.07	555.8	46.53	3.17	4.68	9.99	19.6	15.57
Total Debt/Capital (%)	-27.33	-14.16	-14.17	-24.35	-12.82	-5.21	-3.46	-1.68	-1.01	-0.97
Total Debt/Total Assets (%)	44.86	66.33	36.41	66.49	27.01	2.84	3.79	4.48	9.05	9.4
CFO/Total Liabilities	-55.88	-34.48	-136	-111.04	-151.03	-179.9	-214.81	-105.86	-166.9	-56.05
CFO/CapEx	-17.41	-20.45	-60.12	-483.65	- -	-49.27	-37.8	-74.03	-669.15	- -
Altman's Z-Score	-7.08	-15.03	-3.29	-6.21	8.54	12.18	0.52	-6.23	-17.28	-15.17

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	3.66	3.05	1.87	1.87	4.66	4.65	4.42	4.37	5.73
Days Sales Outstanding	- -	99.82	119.63	195.45	195.51	78.24	78.48	82.57	83.44	63.71
Inventory Turnover	- -	3.45	6.31	3	1.7	1.8	1.04	1.01	1.79	1.85
Days Inventory Outstanding	- -	105.65	57.87	121.67	215.26	203.13	351.92	361.93	204.22	197.34
Accounts Payable Turnover	- -	3.83	4.43	4.51	1.99	3.38	3.37	1.72	2.15	1.54
Accounts Payable Turnover Days	- -	95.31	82.48	80.86	183.4	107.86	108.4	212.52	169.97	237.38
Cash Conversion Cycle	- -	110.16	95.01	236.26	227.36	173.52	322	231.98	117.69	23.67
Inventory to Cash Days	- -	-5.83	61.76	73.78	-19.75	-124.89	-273.44	-279.35	-120.78	-133.63
Inventories	2	2	1	3	3	12	30	23	11	5
Raw Materials	- -	- -	- -	1	2	5	5	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	2	7	- -	- -	- -
Finished Goods	2	1	1	2	1	6	17	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	23	11	5

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	53	43	585	866	434	65	32	8
- Cash & Cash Equivalents	5	1	17	17	38	25	5	18	9	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	7	9	20	16	11	12	10	7	7
Enterprise Value	1	6	45	45	563	626	332	7	30	-4
Total Capital	-24	-48	-64	-82	-127	-205	-337	-572	-686	-713
Total Debt/Capital (%)	-27.33	-14.16	-14.17	-24.35	-12.82	-5.21	-3.46	-1.68	-1.01	-0.97
Total Debt / EV	4.79	1.18	0.2	0.44	0.03	0.02	0.04	1.31	0.23	-1.72
EV/Sales	0.2	0.6	3.77	4.47	66.2	34.81	11.95	0.2	0.97	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	53	43	585	866	434	65	32	8
Diluted Enterprise Value	1	6	45	45	563	852	440	56	30	12
EV per Share	158.81	1,268.13	2,696.84	792.55	1,778.12	1,296.94	671.04	12.94	15.94	- -
TTM Sales	7	10	12	10	9	18	28	36	31	29
TTM EBITDA	-20	-21	-19	-25	-37	-74	-122	-123	-62	-24
TTM Operating Income	-21	-23	-20	-26	-39	-77	-132	-137	-76	-33
TTM Cash Flow to Firm	-23	-20	-19	-27	-36	-71	-125	-128	-67	-16
TTM Free Cash Flow to Firm	-22	-19	-18	-27	-36	-70	-121	-126	-66	-16

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-2.69	-1.44	-15.27	-12.29	-3.57	-0.52	-0.47	-0.51
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	1	6	45	45	563	626	332	7	30	-4
Low Price	- -	- -	54	300	150	1,728	696	71.4	11.64	1.45
EV/Sales	0.2	0.6	3.77	4.47	66.2	34.81	11.95	0.2	0.97	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-2.77	-3.03	-3.03	-26.12	-4.63	-1.04	-0.73	-0.77
Price/Earnings High	- -	- -	-5.44	-7.17	-16.04	-62.73	-9.75	-2.97	-2.16	-4.7
Price/Earnings Low	- -	- -	-0.05	-0.57	-1.16	-11.51	-2.6	-0.17	-0.19	-0.3
Price/Book Value	- -	- -	-0.72	-0.41	-4.07	-4.01	-1.24	-0.11	-0.05	-0.01
Price/Book Value Average	- -	- -	-0.7	-0.88	-0.87	-8.75	-1.76	-0.42	-0.12	-0.03
Price/Book Value High	- -	- -	-1.38	-2.08	-4.59	-21.03	-3.71	-1.19	-0.35	-0.17
Price/Book Value Low	- -	- -	-0.01	-0.17	-0.33	-3.86	-0.99	-0.07	-0.03	-0.01
Price/Tangible Book Value	- -	- -	5.2	11.76	22.13	3.41	3.31	1.04	1.26	0.21
Price/Tangible Book Value Average	- -	- -	5.05	24.97	4.71	7.44	4.69	3.88	3.2	0.51
Price/Tangible Book Value High	- -	- -	9.92	59.14	24.94	17.88	9.87	11.09	9.42	3.1
Price/Tangible Book Value Low	- -	- -	0.09	4.74	1.8	3.28	2.63	0.65	0.85	0.2
Price/Sales	- -	- -	4.39	4.2	68.81	48.16	15.61	1.79	1.05	0.29
Price/Sales Average	- -	- -	4.27	8.91	14.65	105.21	22.1	6.69	2.67	0.72
Price/Sales High	- -	- -	8.38	21.1	77.52	252.7	46.5	19.09	7.86	4.35
Price/Sales Low	- -	- -	0.08	1.69	5.58	46.39	12.4	1.12	0.71	0.28
Price/Cash Flow	- -	- -	-2.64	-1.44	-15.27	-12.04	-3.48	-0.52	-0.47	-0.51
Price/Cash Flow Average	- -	- -	-2.57	-3.06	-3.25	-26.3	-4.92	-1.93	-1.19	-1.25
Price/Cash Flow High	- -	- -	-5.04	-7.24	-17.2	-63.17	-10.36	-5.51	-3.51	-7.6
Price/Cash Flow Low	- -	- -	-0.05	-0.58	-1.24	-11.6	-2.76	-0.32	-0.32	-0.48
Price/Free Cash Flow Average	- -	- -	-2.61	-3.06	-3.25	-26.85	-5.06	-1.96	-1.19	-1.25
Price/Free Cash Flow High	- -	- -	-5.13	-7.25	-17.2	-64.48	-10.64	-5.58	-3.51	-7.6
Price/Free Cash Flow Low	- -	- -	-0.05	-0.58	-1.24	-11.84	-2.84	-0.33	-0.32	-0.48
EV/Sales Average	0.2	0.6	3.64	9.18	12.05	104.43	22.33	6.46	2.6	0.85
EV/Sales High	0.2	0.6	7.75	21.37	74.92	251.93	46.73	18.86	7.78	4.49
EV/Sales Low	0.2	0.6	3.9	1.97	2.98	45.61	12.64	0.89	0.63	0.41
EV/EBITDA Average	-0.07	-0.27	-2.29	-3.76	-2.76	-25.47	-5.1	-1.89	-1.29	-1.03
EV/EBITDA High	-0.07	-0.27	-4.87	-8.75	-17.18	-61.44	-10.66	-5.52	-3.86	-5.42
EV/EBITDA Low	-0.07	-0.27	0.35	-0.8	-0.68	-11.12	-2.88	-0.26	-0.31	-0.5
EV/EBIT Average	-0.07	-0.25	-2.14	-3.59	-2.66	-24.36	-4.71	-1.7	-1.05	-0.73
EV/EBIT High	-0.07	-0.25	-4.56	-8.37	-16.52	-58.75	-9.87	-4.96	-3.14	-3.84
EV/EBIT Low	-0.07	-0.25	0.32	-0.77	-0.66	-10.64	-2.67	-0.24	-0.26	-0.35
Last Price	- -	- -	3,143.99	744	1,848	1,794	876	113.4	17.3	1.53
High Price	- -	- -	5,999.99	3,740.99	2,082	9,413.98	2,610	1,212	129.6	22.8
Enterprise Value Average	1	6	44	93	102	1,878	621	233	80	24
Enterprise Value High	1	6	93	216	637	4,530	1,299	681	240	128
Enterprise Value Low	1	6	-7	20	25	820	351	32	19	12

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	2	11
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	2	5
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	2	5
Revenue per Share	779.7	2,111.76	716.12	177.32	26.86	37.25	56.13	63.47	16.5	5.24
EBITDA per Share	-2,301.81	-4,690.13	-1,139.43	-433.22	-117.1	-152.76	-246.03	-216.72	-33.26	-4.34
Operating Income per Share	-2,429.8	-5,024.28	-1,218.23	-452.96	-121.77	-159.74	-265.89	-241.17	-40.89	-6.12
Basic EPS, GAAP	-2,163.52	-5,191.15	-1,103.74	-521.94	-129.84	-150.07	-267.71	-408.6	-60.05	-4.85
Basic EPS from Cont Ops	-2,163.52	-5,191.15	-1,103.74	-521.94	-129.84	-150.07	-267.71	-408.6	-60.05	-4.85
Diluted EPS, GAAP	-2,163.52	-5,191.15	-1,103.74	-521.94	-129.84	-150.07	-267.71	-408.6	-60.05	-4.85
Diluted EPS from Cont Ops	-2,163.52	-5,191.15	-1,103.74	-521.94	-129.84	-150.07	-267.71	-408.6	-60.05	-4.85
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2,697.01	-4,625.15	-1,190.11	-516.94	-121.02	-149.02	-252	-220	-36.95	-3
Free Cash Flow per Basic Share	-2,851.95	-4,851.28	-1,209.9	-518.01	-121.02	-152.04	-258.67	-222.97	-37	-3
Cash & Equivalents per Share	602.57	227.04	985.96	303.05	121.45	519.22	228.52	117.35	5.08	3.54
Book Value per Share	-3,546.91	-12,056.44	-4,341.89	-1,795.64	-453.79	-447.7	-704.04	-1,021.46	-371.62	-132.16
Tangible Book Value per Share	-3,128.9	-11,159.12	604.93	63.26	83.5	526.48	264.42	109.29	13.76	7.36

Bionano Genomics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)